Projectplus: Expanding Horizons in API & Pharmaceutical Facility Design Solutions

Rasik Patel, Swapneel Vaishnav, Pankaj Patel & Haresh Patel, Designated Partner

Rasik Patel, Swapneel Vaishnav, Pankaj Patel & Haresh Patel

Designated Partner

Pharmaceutical consulting startups are emerging as critical partners in an increasingly complex and regulated industry. Projectplus is a leading industrial project consulting firm offering a wide range of services in a better way to project success. The firm’s expertise spans conceptual/basic design, detail engineering and integrated Civil, Structure, process design solutions, electrical, and piping (MEP) services, along with HVAC, process/utility systems, and safety solutions, all from a single office. The company specializes in delivering 3D design solutions for each project, ensuring precision and integration across all aspects. By leveraging its team's combined expertise and experience, Projectplus can provide proactive, customized solutions that anticipate and resolve challenges, helping clients achieve their objectives efficiently while maintaining the highest industry standards.

Comprehensive Project Support

Projectplus also offers procurement support and construction management services, ensuring smooth project execution. The firm’s approach emphasizes energyefficient, cost-effective designs, with a focus on value engineering and maintenance solutions. By offering endto- end project consulting and engineering, the company helps clients achieve optimized, sustainable outcomes for their projects. “At Projectplus, we stand out by integrating all services under one roof, utilizing 3D technology. Our team is adept at providing cost-effective project as well as process design solutions for the API and API intermediate industries, ensuring attractive paybacks within short timeframes. We have earned a strong reputation in pharmaceutical consulting, highlighted by our successful completion of a major project with a 250 crore investment, designed and executed within just 20 months”, speaks Rasik Patel, Designated Partner, Projectplus.

Projectplus' Civil & Structure Departments have made significant strides in redefining the pharma industry standard for sustainable and cost-effective design. Their dedication to innovation and excellence has yielded impressive results, cementing their position as leaders in the field. The company has a strong focus on serving the pharmaceutical sector, with a major portion of its clientele coming from the API (Active Pharmaceutical Ingredient) industry. It also provides consulting services for formulation (finished dosage forms, tablets/capsules/ injectables) projects, nutraceuticals, cosmeceuticals, High potent and biosafety laboratories up to Level 3.

Projectplus’ growth is driven by client trust & innovative design solutions, as we expand across India & beyond

Rasik Patel, Swapneel Vaishnav, Pankaj Patel & Haresh Patel, Designated Partner

Growing Challenges

Projectplus, while operating in the pharmaceutical industry, particularly in the API (Active Pharmaceutical Ingredient) and API intermediate sectors, faces several challenges. One of the key difficulties is the lack of sufficient attention and consulting support in this sector. Despite the growing demand for APIs and their intermediates, the industry has been largely overlooked by consultants, leading to a significant gap in specialized expertise. Additionally, emerging sectors such as biotechnology, oncology, and vaccines are seeing rapid growth, which brings both opportunities and challenges in terms of staying ahead of innovation, regulatory requirements, and market competition. For Projectplus, navigating this landscape requires overcoming these gaps while capitalizing on the growth potential of these developing sectors.

The Pharma API industry faces several challenges, including regulatory compliance, intense competition, R&D demands, infrastructure upgrades, and environmental concerns. Finding the right consultant to address these issues is a significant hurdle. “We offer the expertise, resources, and experience required to navigate these challenges. Our team consists of professionals with handson experience enabling us to provide effective, value-added solutions. We design facilities with a forward-thinking approach, ensuring compliance with evolving regulations like the revised Schedule-M HVAC requirements, something we implemented five years ahead of the mandate. Projectplus is committed to delivering sustainable, futureproof designs for the pharmaceutical industry”, speaks Pankaj Patel and Haresh Patel, Designated Partners, Projectplus.

The firm’s primary goal is to foster the sustainable growth of its clients in the pharmaceutical sector, particularly within the API industry. The company recognizes the significant challenges the API sector faces in achieving sustainable growth, and aim to support its clients not only in project setup but also in process improvement. The firm’s comprehensive approach includes addressing environmental concerns while implementing innovative solutions. The firm have introduced integrated process design solutions, focusing on process engineering, system designs, customized pilot plant designs, and transitioning from batch processes to continuous processes. Additionally, it also offers expertise in scale-up support, solvent recovery, distillation system design, evaporators, product concentrators, as well as gas scrubbers and absorbers. By adding these services to the portfolio, the firm strive to empower the API industry with enhanced capabilities and efficient, sustainable operations.

"With an average team experience exceeding 15 years, Projectplus is well-equipped to deliver exceptional service and strengthen client partnerships"

Driving Sustainable Growth

The firm aim is to foster the sustainable growth of its clients in the pharmaceutical sector, particularly within the API industry, which faces numerous challenges. The firm provides comprehensive support not only for project setup but also for process improvement and environmental management. Projectplus’s innovative approach includes integrated civil, Structure, process design solutions such as process engineering, distillation system designs, absorber scrubber design, evaporator design, customized pilot plant design, and transitioning from batch to continuous processes. Leveraging its dual experience as both clients and consultants, we offer effective, value-added solutions and proactively address potential issues. With an average team experience exceeding 15 years, Projectplus is wellequipped to deliver exceptional service and strengthen client partnerships.

“Our strength lies in our deep understanding of pharmaceutical processes, with a project-first approach that ensures every aspect is meticulously planned and executed. We provide all key services under one roof without relying on external sub-consultants, allowing us to maintain control over every detail and ensure cohesive project management. Our expertise in HVAC systems, particularly for the pharmaceutical industries, focuses on regulatory compliance with global standards like WHO/ EU GMP and USFDA”, shares Pankaj. The firm assesses product-specific needs, whether for API manufacturing or biosafety labs, to define critical design criteria such as temperature, RH, air quality, differential pressure and backup/redundancy.

Team Expertise

At the firm, the team brings a unique blend of experience, having worked on both sides of the table as clients and as consultants. This dual perspective allows it to craft effective, value-added solutions that not only address current challenges but also anticipate future issues, enabling it to devise proactive strategies and offer innovative solutions. This approach fosters strong, long-term relationships with the clients, built on trust and a deep understanding of their needs. The firm’s team boasts an average of over 15 years of experience, which is significantly higher than the industry average. This wealth of expertise enables it to deliver solutions that are both technically advanced and tailored to the clients' specific requirements. With a deep commitment to excellence, the Projectplus team is wellequipped to provide exceptional service and innovative solutions, ensuring that it meets the evolving demands of the pharmaceutical sector, particularly in the API industry, with precision and efficiency.

Projectplus has seen remarkable growth over the past five years, thanks to strong support from its clients. As the firm continues to evolve, the company roadmap focuses on expanding its expertise in project and process design, particularly for the pharma, API and API intermediate industries. With a client base spread across Gujarat, Maharashtra, Madhya Pradesh, Uttarakhand, and Jammu & Kashmir, the firm aims to extend its reach to other regions within India. Additionally, the firm’s work on a basic detail engineering project for an oncology API facility in Russia marks the beginning of its international expansion. Moving forward, the company plans to explore opportunities beyond India, strengthening its global presence and furthering its impact in the pharmaceutical industry. Projectplus is poised for continued success, leveraging its extensive experience and client support to drive innovation and growth both domestically and internationally, solidifying its role as a leader in the pharmaceutical consulting sector.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.